Opioid Receptor Signal Transduction Mechanisms
暂无分享,去创建一个
[1] H. Loh,et al. μ-Opioid Receptor Agonists Differentially Regulate the Expression of miR-190 and NeuroD , 2010, Molecular Pharmacology.
[2] H. Loh,et al. GRIN1 Regulates μ-Opioid Receptor Activities by Tethering the Receptor and G Protein in the Lipid Raft* , 2009, The Journal of Biological Chemistry.
[3] H. Loh,et al. μ-Opioid Receptor Cell Surface Expression Is Regulated by Its Direct Interaction with Ribophorin I , 2009, Molecular Pharmacology.
[4] L. Terenius. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. , 2009, Acta pharmacologica et toxicologica.
[5] L. Devi,et al. Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimers , 2007 .
[6] M. Rodríguez-Muñoz,et al. Sumoylated RGS-Rz Proteins Act as Scaffolds for Mu-Opioid Receptors and G-Protein Complexes in Mouse Brain , 2007, Neuropsychopharmacology.
[7] S. Lanier,et al. Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. , 2007, Pharmacology & therapeutics.
[8] M. Waldhoer,et al. Ligand‐induced down‐regulation of the cannabinoid 1 receptor is mediated by the G‐protein‐coupled receptor‐associated sorting protein GASP1 , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] K. Martemyanov,et al. The Membrane Anchor R7BP Controls the Proteolytic Stability of the Striatal Specific RGS Protein, RGS9-2*♦ , 2007, Journal of Biological Chemistry.
[10] W. Xu,et al. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. , 2007, Biochemical pharmacology.
[11] R. A. Moyer,et al. An Opioid Agonist that Does Not Induce μ-Opioid Receptor—Arrestin Interactions or Receptor Internalization , 2007, Molecular Pharmacology.
[12] Arthur Christopoulos,et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.
[13] J. Traynor,et al. Mediation of adenylyl cyclase sensitization by PTX‐insensitive GαoA, Gαi1, Gαi2 or Gαi3 , 2006 .
[14] C. Chavkin,et al. Mu Opioid Receptor Activation of ERK1/2 Is GRK3 and Arrestin Dependent in Striatal Neurons* , 2006, Journal of Biological Chemistry.
[15] R. Wesselschmidt,et al. μ- and κ-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors* , 2006, Journal of Biological Chemistry.
[16] L. Burns,et al. Gβγ that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein , 2006 .
[17] Michel Bouvier,et al. Simultaneous Activation of the δ Opioid Receptor (δOR)/Sensory Neuron-Specific Receptor-4 (SNSR-4) Hetero-Oligomer by the Mixed Bivalent Agonist Bovine Adrenal Medulla Peptide 22 Activates SNSR-4 but Inhibits δOR Signaling , 2006, Molecular Pharmacology.
[18] M. Bruchas,et al. Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes* , 2006, Journal of Biological Chemistry.
[19] K. Martemyanov,et al. Subcellular Targeting of RGS9-2 Is Controlled by Multiple Molecular Determinants on Its Membrane Anchor, R7BP* , 2006, Journal of Biological Chemistry.
[20] Z. Vogel,et al. Adenylyl cyclase type II activity is regulated by two different mechanisms: Implications for acute and chronic opioid exposure , 2006, Neuropharmacology.
[21] P. Chong,et al. Localization of the κ Opioid Receptor in Lipid Rafts , 2006, Journal of Pharmacology and Experimental Therapeutics.
[22] H. Hamm,et al. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling. , 2006, Cellular signalling.
[23] J. Traynor,et al. Comparison of the Relative Efficacy and Potency of μ-Opioid Agonists to Activate Gαi/o Proteins Containing a Pertussis Toxin-Insensitive Mutation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[24] P. Chidiac,et al. RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. , 2006, Cellular signalling.
[25] R. Lefkowitz,et al. Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation* , 2006, Journal of Biological Chemistry.
[26] H. Loh,et al. Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor Internalization , 2006, Molecular Pharmacology.
[27] Jian-guo Li,et al. GEC1 Interacts with the κ Opioid Receptor and Enhances Expression of the Receptor* , 2006, Journal of Biological Chemistry.
[28] H. Loh,et al. Short- and Long-Term Regulation of Adenylyl Cyclase Activity by δ-Opioid Receptor Are Mediated by Gαi2 in Neuroblastoma N2A Cells , 2006, Molecular Pharmacology.
[29] Ji Yeoun Yoo,et al. Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[30] B. Sharp,et al. δ Opioid Receptors Stimulate Akt-Dependent Phosphorylation of c-jun in T Cells , 2006, Journal of Pharmacology and Experimental Therapeutics.
[31] A. Gintzler,et al. Phospholipase Cβ1 modulates pain sensitivity, opioid antinociception and opioid tolerance formation , 2006, Brain Research.
[32] D. Roden,et al. Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice , 2005 .
[33] M. Zerial,et al. Phosphorylation of EEA1 by p38 MAP kinase regulates μ opioid receptor endocytosis , 2005, The EMBO journal.
[34] P. Insel,et al. G-protein-coupled Receptor Signaling Components Localize in Both Sarcolemmal and Intracellular Caveolin-3-associated Microdomains in Adult Cardiac Myocytes* , 2005, Journal of Biological Chemistry.
[35] A. López-Fando,et al. The RGSZ2 Protein Exists in a Complex with μ-Opioid Receptors and Regulates the Desensitizing Capacity of Gz Proteins , 2005, Neuropsychopharmacology.
[36] M. von Zastrow,et al. Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of μ-Opioid Receptors in Striatal Neurons , 2005, The Journal of Neuroscience.
[37] C. Coscia,et al. μ and κ Opioid Receptors Activate ERK/MAPK via Different Protein Kinase C Isoforms and Secondary Messengers in Astrocytes* , 2005, Journal of Biological Chemistry.
[38] Jamie Fong,et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] K. Mcfarland,et al. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[40] Xiaochun Sun,et al. Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.
[41] Maureen P. Boyle,et al. Palmitoylation regulates plasma membrane–nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family , 2005, The Journal of cell biology.
[42] M. Rodríguez-Muñoz,et al. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter , 2005, Neuropharmacology.
[43] Robert J. Lefkowitz,et al. Transduction of Receptor Signals by ß-Arrestins , 2005, Science.
[44] A. Burlingame,et al. Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. , 2005, Biochemistry.
[45] A. López-Fando,et al. Activation of μ-Opioid Receptors Transfers Control of Gα Subunits to the Regulator of G-protein Signaling RGS9-2 , 2005, Journal of Biological Chemistry.
[46] V. Arshavsky,et al. R7BP, a Novel Neuronal Protein Interacting with RGS Proteins of the R7 Family* , 2005, Journal of Biological Chemistry.
[47] M. Rodríguez-Muñoz,et al. RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Gαz subunits , 2005, Neuropharmacology.
[48] B. Ersbøll,et al. A Library of 7TM Receptor C-terminal Tails , 2004, Journal of Biological Chemistry.
[49] G. Dubyak,et al. Erratum: Maitotoxin induces biphasic interleukin-1β secretion and membrane blebbing in murine macrophages (Molecular Pharmacology (2004) 66 (909-920)) , 2004 .
[50] T. Su,et al. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. , 2004, Molecular pharmacology.
[51] R. Lefkowitz,et al. Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor* , 2004, Journal of Biological Chemistry.
[52] M. Caron,et al. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. , 2004, Molecular pharmacology.
[53] R. Neubig,et al. Endogenous Regulator of G Protein Signaling Proteins Suppress Gαo-Dependent, μ-Opioid Agonist-Mediated Adenylyl Cyclase Supersensitization , 2004, Journal of Pharmacology and Experimental Therapeutics.
[54] Angel Y. F. Kam,et al. Regulation of STAT3 by μ-opioid receptors in human neuroblastoma SH-SY5Y cells , 2004 .
[55] Zhe Ding,et al. κ Opioid Receptor Interacts with Na+/H+-exchanger Regulatory Factor-1/Ezrin-Radixin-Moesin-binding Phosphoprotein-50 (NHERF-1/EBP50) to Stimulate Na+/H+ Exchange Independent of Gi/Go Proteins* , 2004, Journal of Biological Chemistry.
[56] S. Snyder,et al. Inositol 1,4,5-trisphosphate receptors as signal integrators. , 2004, Annual review of biochemistry.
[57] A. García-España,et al. RGSZ1 and GAIP Regulate μ- but Not δ-Opioid Receptors in Mouse CNS: Role in Tachyphylaxis and Acute Tolerance , 2004, Neuropsychopharmacology.
[58] R. Schulz,et al. Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinases Block Internalization of δ-Opioid Receptors , 2004, Journal of Pharmacology and Experimental Therapeutics.
[59] F. Simonin,et al. Identification of a novel family of G protein‐coupled receptor associated sorting proteins , 2004, Journal of neurochemistry.
[60] Christopher C Lapish,et al. Activator of G Protein Signaling 3 A Gatekeeper of Cocaine Sensitization and Drug Seeking , 2004, Neuron.
[61] Lakshmi A. Devi,et al. A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia , 2004 .
[62] R. Fisher,et al. RGS6 Interacts with DMAP1 and DNMT1 and Inhibits DMAP1 Transcriptional Repressor Activity* , 2004, Journal of Biological Chemistry.
[63] Y. Wong,et al. Phosphatidylinositol‐3 kinase is distinctively required for µ‐, but not κ‐opioid receptor‐induced activation of c‐Jun N‐terminal kinase , 2004, Journal of neurochemistry.
[64] M. Stoffel,et al. Spinal G-Protein-Gated K+ Channels Formed by GIRK1 and GIRK2 Subunits Modulate Thermal Nociception and Contribute to Morphine Analgesia , 2004, The Journal of Neuroscience.
[65] M. Narita,et al. Role of extracellular signal‐regulated kinase in the ventral tegmental area in the suppression of the morphine‐induced rewarding effect in mice with sciatic nerve ligation , 2004, Journal of neurochemistry.
[66] S. Schulz,et al. Heterodimerization of Substance P and μ-Opioid Receptors Regulates Receptor Trafficking and Resensitization* , 2003, Journal of Biological Chemistry.
[67] C. Coscia,et al. μ Opioid Transactivation and Down-Regulation of the Epidermal Growth Factor Receptor in Astrocytes: Implications for Mitogen-Activated Protein Kinase Signaling , 2003 .
[68] Wei Xu,et al. Differential Effects of Agonists on Adenylyl Cyclase Superactivation Mediated by the κ Opioid Receptors: Adenylyl Cyclase Superactivation Is Independent of Agonist-Induced Phosphorylation, Desensitization, Internalization, and Down-Regulation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[69] M. Groszer,et al. Phosphoinositide 3-Kinase Cascade Facilitates μ-Opioid Desensitization in Sensory Neurons by Altering G-Protein-Effector Interactions , 2003, The Journal of Neuroscience.
[70] E. J. Simon,et al. Interaction Between the μ Opioid Receptor and Filamin A Is Involved in Receptor Regulation and Trafficking , 2003 .
[71] M. Bootman,et al. Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization. , 2003, The Biochemical journal.
[72] A. López-Fando,et al. The R7 Subfamily of RGS Proteins Assists Tachyphylaxis and Acute Tolerance at μ-Opioid Receptors , 2003, Neuropsychopharmacology.
[73] E. Nestler,et al. Essential role for RGS9 in opiate action , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[74] H. Loh,et al. μ-Opioid Receptor Desensitization , 2003, Journal of Biological Chemistry.
[75] R. Polakiewicz,et al. Behavioral/systems/cognitive Brain Region-specific Mechanisms for Acute Morphine- Induced Mitogen-activated Protein Kinase Modulation and Distinct Patterns of Activation during Analgesic Tolerance and Locomotor Sensitization Opioid-receptor Activation in Cell Lines Results in Phosphorylation of P42/ , 2022 .
[76] K. Mackie,et al. Phosphorylation of a Carboxyl-terminal Serine within the κ-Opioid Receptor Produces Desensitization and Internalization* , 2003, Journal of Biological Chemistry.
[77] G. Pei,et al. A novel function of Goα: mediation of extracellular signal‐regulated kinase activation by opioid receptors in neural cells , 2003, Journal of neurochemistry.
[78] L. Hunyady,et al. Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[79] M. von Zastrow,et al. Spatial regulation of Galphai protein signaling in clathrin-coated membrane microdomains containing GAIP. , 2003, Molecular pharmacology.
[80] P. Eriksson,et al. Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors , 2003, Molecular and Cellular Neuroscience.
[81] A. López-Fando,et al. The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects , 2003, Neuropharmacology.
[82] V. Hruby,et al. Converging Protein Kinase Pathways Mediate Adenylyl Cyclase Superactivation upon Chronic δ-Opioid Agonist Treatment , 2003, Journal of Pharmacology and Experimental Therapeutics.
[83] Krzysztof Palczewski,et al. Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.
[84] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[85] H. Loh,et al. Ligand-Selective Activation of μ-Opioid Receptor: Demonstrated with Deletion and Single Amino Acid Mutations of Third Intracellular Loop Domain , 2003, Journal of Pharmacology and Experimental Therapeutics.
[86] M. Barrot,et al. Morphine Acutely Regulates Opioid Receptor Trafficking Selectively in Dendrites of Nucleus Accumbens Neurons , 2003, The Journal of Neuroscience.
[87] R. Neubig,et al. Endogenous RGS Protein Action Modulates μ-Opioid Signaling through Gαo , 2003, The Journal of Biological Chemistry.
[88] S. Schulz,et al. ADP-ribosylation Factor-dependent Phospholipase D2 Activation Is Required for Agonist-induced μ-Opioid Receptor Endocytosis* , 2003, The Journal of Biological Chemistry.
[89] M. Iglesias,et al. μ-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase , 2003, Neuropharmacology.
[90] P. Eriksson,et al. Mu‐ and delta‐opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors , 2003, The European journal of neuroscience.
[91] M. Rhee,et al. Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine , 2003, Journal of Pharmacology and Experimental Therapeutics.
[92] G. Aghajanian,et al. Regulation of RGS proteins by chronic morphine in rat locus coeruleus , 2003, The European journal of neuroscience.
[93] Y. Sarne,et al. The mu opioid agonist DAMGO stimulates cAMP production in SK-N-SH cells through a PLC-PKC-Ca++ pathway. , 2003, Brain research. Molecular brain research.
[94] Angel Y. F. Kam,et al. Rac and Cdc42‐dependent regulation of c‐Jun N‐terminal kinases by the δ‐opioid receptor , 2003 .
[95] J. M. Ree,et al. ERK1/2 activation in rat ventral tegmental area by the μ-opioid agonist fentanyl: an in vitro study , 2003, Neuroscience.
[96] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[97] M. Stoffel,et al. Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice , 2002, Neuroreport.
[98] C. Coscia,et al. The Fibroblast Growth Factor Receptor Is at the Site of Convergence between μ-Opioid Receptor and Growth Factor Signaling Pathways in Rat C6 Glioma Cells , 2002, Journal of Pharmacology and Experimental Therapeutics.
[99] H. Ammer,et al. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid‐induced adenylyl cyclase supersensitivity , 2002, Journal of neurochemistry.
[100] R. Lefkowitz,et al. Regulation of G protein-coupled receptor signaling by scaffold proteins. , 2002, Circulation research.
[101] L. Monticelli,et al. Selective Ligand-induced Stabilization of Active and Desensitized Parathyroid Hormone Type 1 Receptor Conformations* , 2002, The Journal of Biological Chemistry.
[102] R. Fisher,et al. RGS6 Interacts with SCG10 and Promotes Neuronal Differentiation , 2002, The Journal of Biological Chemistry.
[103] M. Sugiyama,et al. Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. , 2002, European journal of pharmacology.
[104] M. Nemoto,et al. Implications of phosphoinositide 3-kinase in the μ- and δ-opioid receptor-mediated supraspinal antinociception in the mouse , 2002, Neuroscience.
[105] J. Hepler,et al. Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling , 2002, Pharmacological Reviews.
[106] W. Sadee,et al. Differential Effects of μ-Opioid Receptor Ligands on Ca2+ Signaling , 2002 .
[107] Jian-guo Li,et al. Ezrin-Radixin-Moesin-binding Phosphoprotein-50/Na+/H+ Exchanger Regulatory Factor (EBP50/NHERF) Blocks U50,488H-induced Down-regulation of the Human κ Opioid Receptor by Enhancing Its Recycling Rate* , 2002, The Journal of Biological Chemistry.
[108] M. von Zastrow,et al. Modulation of Postendocytic Sorting of G Protein-Coupled Receptors , 2002, Science.
[109] M. Stoffel,et al. G-Protein-Gated Potassium Channels Containing Kir3.2 and Kir3.3 Subunits Mediate the Acute Inhibitory Effects of Opioids on Locus Ceruleus Neurons , 2002, The Journal of Neuroscience.
[110] M. Narita,et al. Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain , 2002, Neuroscience Letters.
[111] B. Kasinath,et al. Role of P38 Mitogen-Activated Protein Kinase Phosphorylation and Fas-Fas Ligand Interaction in Morphine-Induced Macrophage Apoptosis1 , 2002, The Journal of Immunology.
[112] Y. Wong,et al. Co-Expressions of Different Opioid Receptor Types Differentially Modulate Their Signaling via G16 , 2002, Neurosignals.
[113] L. Limbird,et al. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. , 2002, Cellular signalling.
[114] M. Caron,et al. β-Arrestin/AP-2 Interaction in G Protein-coupled Receptor Internalization , 2002, The Journal of Biological Chemistry.
[115] R. Ostrom,et al. New determinants of receptor-effector coupling: trafficking and compartmentation in membrane microdomains. , 2002, Molecular pharmacology.
[116] E. J. Simon,et al. Delta Opioid activation of the Mitogen-activated protein kinase cascade does not require transphosphorylation of Receptor Tyrosine Kinases , 2002, BMC pharmacology.
[117] I. Zagon,et al. The biology of the opioid growth factor receptor (OGFr) , 2002, Brain Research Reviews.
[118] L. Bohn,et al. Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. , 2001, Journal of neurochemistry.
[119] Y. Wong,et al. Role of extracellular signal-regulated kinases in opioid-induced adenylyl cyclase superactivation in human embryonic kidney 293 cells , 2001, Neuroscience Letters.
[120] R. Lefkowitz,et al. β-Arrestin-mediated ADP-ribosylation Factor 6 Activation and β2-Adrenergic Receptor Endocytosis* , 2001, The Journal of Biological Chemistry.
[121] C. Ross,et al. β1-Adrenergic Receptor Association with the Synaptic Scaffolding Protein Membrane-associated Guanylate Kinase Inverted-2 (MAGI-2) , 2001, The Journal of Biological Chemistry.
[122] T. Kroslak,et al. Human Phosphatidylethanolamine-binding Protein Facilitates Heterotrimeric G Protein-dependent Signaling* , 2001, The Journal of Biological Chemistry.
[123] J. Boulter,et al. Functional Properties of CaV1.3 (α1D) L-type Ca2+ Channel Splice Variants Expressed by Rat Brain and Neuroendocrine GH3 Cells* , 2001, The Journal of Biological Chemistry.
[124] T. Kohout,et al. Regulation of Receptor Fate by Ubiquitination of Activated β2-Adrenergic Receptor and β-Arrestin , 2001, Science.
[125] H. Morikawa,et al. Activation of &mgr;-Opioid Receptor Induces Expression of c-fos and junBvia Mitogen-activated Protein Kinase Cascade , 2001, Anesthesiology.
[126] Robert J. Lefkowitz,et al. Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors , 2001, Nature Reviews Neuroscience.
[127] W. Sadee,et al. Single Nucleotide Polymorphisms in the Human μ Opioid Receptor Gene Alter Basal G Protein Coupling and Calmodulin Binding* , 2001, The Journal of Biological Chemistry.
[128] W. Sadee,et al. μ-Opioid Receptor-mediated ERK Activation Involves Calmodulin-dependent Epidermal Growth Factor Receptor Transactivation* , 2001, The Journal of Biological Chemistry.
[129] R. Fryer,et al. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. , 2001, American journal of physiology. Heart and circulatory physiology.
[130] E. Chatzaki,et al. The Fas/FasL apoptotic pathway is involved in kappa-opioid-induced apoptosis of human endometrial stromal cells. , 2001, Molecular human reproduction.
[131] Robert J. Lefkowitz,et al. Identification of a Motif in the Carboxyl Terminus of β-Arrestin2 Responsible for Activation of JNK3* , 2001, The Journal of Biological Chemistry.
[132] Y. Wong,et al. Gα14 links a variety of Gi‐ and Gs‐coupled receptors to the stimulation of phospholipase C , 2001 .
[133] S. Frank,et al. The Angiotensin II-dependent Nuclear Translocation of Stat1 Is Mediated by the Jak2 Protein Motif231YRFRR* , 2001, The Journal of Biological Chemistry.
[134] M. Oppermann,et al. Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: A novel mechanism for modulating cell signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[135] G. Milligan,et al. The human δ opioid receptor activates Gi1α more efficiently than Go1α , 2001, Journal of neurochemistry.
[136] F. Gunn-Moore,et al. Coincident signalling between the Gi/Go‐coupled δ‐opioid receptor and the Gq‐coupled m3 muscarinic receptor at the level of intracellular free calcium in SH‐SY5Y cells , 2001, Journal of neurochemistry.
[137] R. Fryer,et al. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection , 2001, Basic Research in Cardiology.
[138] Gang Pei,et al. Direct binding of β‐arrestins to two distinct intracellular domains of the δ opioid receptor , 2001 .
[139] Robert J. Lefkowitz,et al. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[140] Wei Hu,et al. Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of δ-Opioid Receptor at Serine 344, Resulting in β-Arrestin- and Clathrin-mediated Receptor Internalization* , 2001, The Journal of Biological Chemistry.
[141] P. Sánchez-Blázquez,et al. RGS9 proteins facilitate acute tolerance to mu‐opioid effects , 2001, The European journal of neuroscience.
[142] P. Pratt,et al. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. , 2001, The Journal of pharmacology and experimental therapeutics.
[143] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[144] D P Siderovski,et al. Activator of G protein signaling 3 is a guanine dissociation inhibitor for Galpha i subunits. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[145] Y. J. Lin,et al. Altered gating of opiate receptor-modulated K+ channels on amygdala neurons of morphine-dependent rats. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[146] Lan Li,et al. κ-Opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell line , 2000 .
[147] Liaoyuan A. Hu,et al. β1-Adrenergic Receptor Association with PSD-95 , 2000, The Journal of Biological Chemistry.
[148] Marc G. Caron,et al. μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence , 2000, Nature.
[149] R. Lefkowitz,et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. , 2000, Science.
[150] Lakshmi A. Devi,et al. Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.
[151] B. Tabakoff,et al. Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine. , 2000, Molecular pharmacology.
[152] H. Loh,et al. Deltorphin II-induced Rapid Desensitization of δ-Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor* , 2000, The Journal of Biological Chemistry.
[153] J. Grider,et al. Heterologous desensitization of response mediated by selective PKC-dependent phosphorylation of G(i-1) and G(i-2). , 2000, American journal of physiology. Cell physiology.
[154] Lakshmi A Devi,et al. Opioids and Their Complicated Receptor Complexes , 2000, Neuropsychopharmacology.
[155] N. Bunnett,et al. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[156] M. Ohsawa,et al. Role of the phosphatidylinositol-specific phospholipase C pathway in δ-opioid receptor-mediated antinociception in the mouse spinal cord , 2000, Neuroscience.
[157] E. J. Simon,et al. μ and δ-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization , 2000, Neuropharmacology.
[158] H. Niki,et al. Involvement of G-protein-activated inwardly rectifying K+ (GIRK) channels in opioid-induced analgesia , 2000, Neuroscience Research.
[159] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[160] T. Kroslak,et al. Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling. , 2000, Molecular pharmacology.
[161] W. Sadee,et al. Calmodulin Regulation of Basal and Agonist‐Stimulated G Protein Coupling by the μ‐Opioid Receptor (OP3) in Morphine‐Pretreated Cell , 2000, Journal of neurochemistry.
[162] M. Caron,et al. The Interaction of β-Arrestin with the AP-2 Adaptor Is Required for the Clustering of β2-Adrenergic Receptor into Clathrin-coated Pits* , 2000, The Journal of Biological Chemistry.
[163] Y. Wong,et al. Evidence for transduction of mu but not kappa opioid modulation of extracellular signal-regulated kinase activity by G(z) and G(12) proteins. , 2000, Cellular signalling.
[164] H. Loh,et al. Association of a Lower Molecular Weight Protein to the μ‐Opioid Receptor Demonstrated by 125I‐β‐Endorphin Cross‐Linking Studies , 2000 .
[165] K. Bernstein,et al. Jak2 Acts as Both a STAT1 Kinase and as a Molecular Bridge Linking STAT1 to the Angiotensin II AT1 Receptor* , 2000, The Journal of Biological Chemistry.
[166] R. Lefkowitz,et al. β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC , 2000, The Journal of Biological Chemistry.
[167] Y. Wong,et al. Regulation of Adenylyl Cyclase, ERK1/2, and CREB by Gz Following Acute and Chronic Activation of the δ‐Opioid Receptor , 2000, Journal of neurochemistry.
[168] Y. Wong,et al. Preactivation permits subsequent stimulation of phospholipase C by G(i)-coupled receptors. , 2000, Molecular pharmacology.
[169] L. Devi,et al. Opioid receptor endocytosis and activation of MAP kinase pathway. , 2000, Brain research. Molecular brain research.
[170] E. Chalecka‐Franaszek,et al. Immunoprecipitation of High‐Affinity, Guanine Nucleotide‐Sensitive, Solubilized μ‐Opioid Receptors from Rat Brain , 2000 .
[171] E. Chalecka‐Franaszek,et al. Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3). , 2000, Journal of neurochemistry.
[172] L. Bohn,et al. μ‐Opioid Agonist Inhibition of κ‐Opioid Receptor‐Stimulated Extracellular Signal‐Regulated Kinase Phosphorylation Is Dynamin‐Dependent in C6 Glioma Cells , 2000 .
[173] V. Höllt,et al. Involvement of Mitogen‐Activated Protein Kinase in Agonist‐Induced Phosphorylation of the μ‐Opioid Receptor in HEK 293 Cells , 2000, Journal of neurochemistry.
[174] R. Gainetdinov,et al. Enhanced morphine analgesia in mice lacking beta-arrestin 2. , 1999, Science.
[175] H. Loh,et al. δ-opioid-induced liberation of Gβγ mobilizes Ca2+ stores in NG108- 15 cells , 1999 .
[176] E. Nestler,et al. Effects of regulators of G protein-signaling proteins on the functional response of the mu-opioid receptor in a melanophore-based assay. , 1999, The Journal of pharmacology and experimental therapeutics.
[177] G. Pei,et al. Endogenous δ‐Opioid and ORL1 Receptors Couple to Phosphorylation and Activation of p38 MAPK in NG108‐15 Cells and This Is Regulated by Protein Kinase A and Protein Kinase C , 1999 .
[178] A. Bretscher,et al. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor , 1999, Nature.
[179] R. Gross,et al. Genetic alteration of phospholipase C β3 expression modulates behavioral and cellular responses to μ opioids , 1999 .
[180] M. von Zastrow,et al. Dissociation of Functional Roles of Dynamin in Receptor-mediated Endocytosis and Mitogenic Signal Transduction* , 1999, The Journal of Biological Chemistry.
[181] E M Ross,et al. Rapid GTP binding and hydrolysis by G(q) promoted by receptor and GTPase-activating proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[182] W. Sadee,et al. Calmodulin Binding to G Protein-coupling Domain of Opioid Receptors* , 1999, The Journal of Biological Chemistry.
[183] K. Fukuda,et al. Opioid potentiation of N-type Ca2+ channel currents via pertussis-toxin-sensitive G proteins in NG108-15 cells , 1999, Pflügers Archiv.
[184] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[185] M. T. Frejo,et al. Stimulation of μ‐ and δ‐opioid receptors enhances phosphoinositide metabolism in mouse spinal cord: evidence for subtypes of δ‐receptors , 1999, The European journal of neuroscience.
[186] J. Benovic,et al. U50,488H-induced Internalization of the Human κ Opioid Receptor Involves a β-Arrestin- and Dynamin-dependent Mechanism , 1999, The Journal of Biological Chemistry.
[187] R. Lefkowitz,et al. Identification of NSF as a β-Arrestin1-binding Protein , 1999, The Journal of Biological Chemistry.
[188] H. Loh,et al. The Absence of a Direct Correlation between the Loss of [d-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced μ-Opioid Receptor Phosphorylation* , 1999, The Journal of Biological Chemistry.
[189] G L Johnson,et al. Organization and regulation of mitogen-activated protein kinase signaling pathways. , 1999, Current opinion in cell biology.
[190] J. Pintar,et al. μ‐opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR‐1 , 1999, British journal of pharmacology.
[191] Gang Pei,et al. Modulation of Ca2+/Calmodulin-Dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of α and β Isoforms , 1999 .
[192] N. Akaike,et al. μ-opioid agonist-induced activation of G-protein-coupled inwardly rectifying potassium current in rat periaqueductal gray neurons , 1999, Neuroscience.
[193] E. J. Simon,et al. Role of Protein Kinase C (PKC) in Agonist‐Induced α‐Opioid Receptor Down‐Regulation , 1999 .
[194] Y. Daaka,et al. Delta opioid receptors expressed by stably transfected jurkat cells signal through the map kinase pathway in a ras-independent manner , 1999, Journal of Neuroimmunology.
[195] E. J. Simon,et al. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. , 1999, Journal of neurochemistry.
[196] Y. Wong,et al. Stimulation of phospholipase C by the cloned μ, δ and κ opioid receptors via chimeric Gαq mutants , 1999, The European journal of neuroscience.
[197] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[198] L. Bohn,et al. Requirement of Receptor Internalization for Opioid Stimulation of Mitogen-Activated Protein Kinase: Biochemical and Immunofluorescence Confocal Microscopic Evidence , 1999, The Journal of Neuroscience.
[199] Kenneth A. Jones,et al. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.
[200] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[201] Y. Kurachi,et al. G protein regulation of potassium ion channels. , 1998, Pharmacological reviews.
[202] S. P. Schneider,et al. Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. , 1998, Journal of neurophysiology.
[203] W. J. Tang,et al. Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. , 1998, Molecular pharmacology.
[204] B. Hille,et al. G-Protein β-Subunit Specificity in the Fast Membrane-Delimited Inhibition of Ca2+ Channels , 1998, The Journal of Neuroscience.
[205] M. Marrero,et al. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. , 1998, American journal of physiology. Cell physiology.
[206] T. Wong,et al. Phospholipase C inhibitors attenuate arrhythmias induced by kappa-receptor stimulation in the isolated rat heart. , 1998, Journal of molecular and cellular cardiology.
[207] W. J. Tang,et al. Chronic morphine augments G(beta)(gamma)/Gs(alpha) stimulation of adenylyl cyclase: relevance to opioid tolerance. , 1998, Molecular pharmacology.
[208] M. von Zastrow,et al. Phosphorylation Is Not Required for Dynamin-dependent Endocytosis of a Truncated Mutant Opioid Receptor* , 1998, The Journal of Biological Chemistry.
[209] C. Barnes,et al. Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity , 1998, The Journal of Neuroscience.
[210] A. Gingras,et al. μ-Opioid Receptor Activates Signaling Pathways Implicated in Cell Survival and Translational Control* , 1998, The Journal of Biological Chemistry.
[211] B. Hawes,et al. Nociceptin (ORL‐1) and μ‐Opioid Receptors Mediate Mitogen‐Activated Protein Kinase Activation in CHO Cells Through a Gi‐Coupled Signaling Pathway: Evidence for Distinct Mechanisms of Agonist‐Mediated Desensitization , 1998, Journal of neurochemistry.
[212] J. Whistler,et al. Morphine-activated opioid receptors elude desensitization by β-arrestin , 1998 .
[213] S. Rees,et al. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor. , 1998, Biochemistry.
[214] J. Hurley,et al. Catalytic mechanism and regulation of mammalian adenylyl cyclases. , 1998, Molecular pharmacology.
[215] Robert J. Lefkowitz,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[216] P. Leff,et al. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.
[217] H. Loh,et al. Distinct Differences Between Morphine‐ and [d‐Ala2,N‐MePhe4,Gly‐ol5]‐Enkephalin‐ μ‐Opioid Receptor Complexes Demonstrated by Cyclic AMP‐Dependent Protein Kinase Phosphorylation , 1998, Journal of neurochemistry.
[218] M. Caron,et al. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[219] H. Loh,et al. Contribution of phospholipase C-beta3 phosphorylation to the rapid attenuation of opioid-activated phosphoinositide response. , 1998, Molecular pharmacology.
[220] M. Comb,et al. A Mitogen-activated Protein Kinase Pathway Is Required for μ-Opioid Receptor Desensitization* , 1998, The Journal of Biological Chemistry.
[221] Y. Sarne,et al. Dissociation between the inhibitory and stimulatory effects of opioid peptides on cAMP formation in SK-N-SH neuroblastoma cells. , 1998, Biochemical and biophysical research communications.
[222] E. Stefani,et al. Functional coupling between human E‐type Ca2+ channels and μ opioid receptors expressed in Xenopus oocytes , 1998, FEBS letters.
[223] D. McKean,et al. Signaling through Delta Opioid Receptors on Murine Splenic T Cells and Stably Transfected Jurkat Cells , 1998, Annals of the New York Academy of Sciences.
[224] Y. Wong,et al. Differential Coupling of μ‐, δ‐, and κ‐Opioid Receptors to Gα16‐Mediated Stimulation of Phospholipase C , 1998 .
[225] P. Sánchez-Blázquez,et al. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. , 1998, The Journal of pharmacology and experimental therapeutics.
[226] S. Shenolikar,et al. The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange , 1998, Nature.
[227] S. Sealfon,et al. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D , 1998, Nature.
[228] M. Peyton,et al. Multiple neurological abnormalities in mice deficient in the G protein Go. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[229] V. Höllt,et al. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine‐dependent rats in vivo , 1998, The European journal of neuroscience.
[230] A. Hsu,et al. TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. , 1998, American journal of physiology. Heart and circulatory physiology.
[231] D. Hilgemann,et al. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gβγ , 1998, Nature.
[232] Z. Vogel,et al. Opioid Modulation of Extracellular Signal‐Regulated Protein Kinase Activity Is Ras‐Dependent and Involves Gβγ Subunits , 1998 .
[233] G. Pei,et al. Suppression of phospholipase C blocks Gi-mediated inhibition of adenylyl cyclase activity. , 1998, European journal of pharmacology.
[234] G. Pei,et al. Inhibition of phospholipase C blocks opioid receptor‐mediated activation of Gi proteins , 1998, Neuroreport.
[235] V. Hruby,et al. Opioid Peptides: Simultaneous δ Agonism and μ Antagonism in Somatostatin Analogues , 1997, Peptides.
[236] K. Kalli,et al. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. , 1997, Journal of immunology.
[237] S. Appleyard,et al. Agonist‐Induced Phosphorylation of the κ‐Opioid Receptor , 1997 .
[238] R. Schulz,et al. Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gs alpha. , 1997, Molecular pharmacology.
[239] G. Uhl,et al. μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy* , 1997, The Journal of Biological Chemistry.
[240] G. Pei,et al. Modulation by calcium/calmodulin-dependent protein kinase II of functional response of delta opioid receptor in neuroblastoma x glioma hybrid (NG108-15) cells , 1997, Neuropharmacology.
[241] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[242] R. J. Spencer,et al. Mobilization of Ca2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. , 1997, Biochemical pharmacology.
[243] T. Kroslak,et al. Site Mutation in the Rat μ‐Opioid Receptor Demonstrates the Involvement of Calcium/Calmodulin‐Dependent Protein Kinase II in Agonist‐Mediated Desensitization , 1997, Journal of neurochemistry.
[244] L. Pu,et al. Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins , 1997, Neuroscience Research.
[245] M. Marrero,et al. Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 Receptor* , 1997, The Journal of Biological Chemistry.
[246] G. Milligan,et al. Agonist-mediated tyrosine phosphorylation of isoforms of the shc adapter protein by the delta opioid receptor. , 1997, Cellular signalling.
[247] Emiko Suzuki,et al. A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade , 1997, Nature.
[248] G. Milligan,et al. Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase. , 1997, The Biochemical journal.
[249] S. Law,et al. Changes in the association of G protein subunits with the cloned mouse delta opioid receptor on agonist stimulation. , 1997, The Journal of pharmacology and experimental therapeutics.
[250] C. Kuhn,et al. Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats. , 1997, The Journal of pharmacology and experimental therapeutics.
[251] Y. Jan,et al. Binding of the G protein βγ subunit to multiple regions of G protein‐gated inward‐rectifying K+ channels , 1997 .
[252] N. Akaike,et al. Modulation of high-voltage activated Ca2+ channels in the rat periaqueductal gray neurons by mu-type opioid agonist. , 1997, Journal of neurophysiology.
[253] K. Hirota,et al. The effects of recombinant rat μ‐opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase , 1997, British journal of pharmacology.
[254] Z. Vogel,et al. Opiate-induced Adenylyl Cyclase Superactivation Is Isozyme-specific* , 1997, The Journal of Biological Chemistry.
[255] W. Catterall,et al. Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel α1A subunit , 1997 .
[256] S. Allouche,et al. The δ‐Opioid Receptor Regulates Activity of Ryanodine Receptors in the Human Neuroblastoma Cell Line SK‐N‐BE , 1996, Journal of neurochemistry.
[257] G. Milligan,et al. Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. , 1996, The Biochemical journal.
[258] K. Shen,et al. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence , 1996, Neurochemical Research.
[259] J. Benovic,et al. β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.
[260] G. Makhlouf,et al. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. , 1996, Molecular pharmacology.
[261] T. Hales,et al. Voltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors. , 1996, Molecular pharmacology.
[262] K. Chang,et al. The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. , 1996, Molecular pharmacology.
[263] K. Fukuda,et al. Functional Coupling of the δ‐, μ‐, and κ‐Opioid Receptors to Mitogen‐Activated Protein Kinase and Arachidonate Release in Chinese Hamster Ovary Cells , 1996 .
[264] Z. Vogel,et al. Chronic Opioid Treatment Induces Adenylyl Cyclase V Superactivation , 1996, The Journal of Biological Chemistry.
[265] Christopher J. Evans,et al. Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.
[266] K. Yan,et al. A Domain on the G Protein β Subunit Interacts with Both Adenylyl Cyclase 2 and the Muscarinic Atrial Potassium Channel* , 1996, The Journal of Biological Chemistry.
[267] R. Miller,et al. Mechanism of inhibition of calcium channels in rat nucleus tractus solitarius by neurotransmitters , 1996, British journal of pharmacology.
[268] D. Lambert,et al. Tyr-D-Arg2-Phe-sarcosine4 activates phospholipase C-coupled mu2-opioid receptors in SH-SY5Y cells. , 1996, European journal of pharmacology.
[269] F. F. Weight,et al. Differential Opiate Receptor Phosphorylation and Desensitization Induced by Agonists and Phorbol Esters (*) , 1996, The Journal of Biological Chemistry.
[270] R. Stephens,et al. Structural Requirements of Heparin Binding to Chlamydia trachomatis(*) , 1996, The Journal of Biological Chemistry.
[271] K. Mackie,et al. Modulation of Ca2+ channels by G-protein βγ subunits , 1996, Nature.
[272] S. Ikeda. Voltage-dependent modulation of N-type calcium channels by G-protein β γsubunits , 1996, Nature.
[273] K. Mackie,et al. Modulation of Ca2+ channels βγ G-protein py subunits , 1996, Nature.
[274] T. Soong,et al. Determinants of the G protein-dependent opioid modulation of neuronal calcium channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[275] D. Lawrence,et al. Precision Substrate Targeting of Protein Kinases , 1996, The Journal of Biological Chemistry.
[276] M. Connor,et al. δ‐ and μ‐opioid receptor mobilization of intracellular calcium in SH‐SY5Y human neuroblastoma cells , 1996 .
[277] M. Olianas,et al. Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb. , 1995, The Journal of pharmacology and experimental therapeutics.
[278] Y. Wong,et al. Activation of Type II Adenylyl Cyclase by the Cloned μ‐Opioid Receptor: Coupling to Multiple G Proteins , 1995, Journal of neurochemistry.
[279] T. Coderre,et al. Attenuation of morphine tolerance and dependence with the highly selective δ-opioid receptor antagonist TIPP[ψ] , 1995 .
[280] Y. Jan,et al. Evidence that direct binding of Gβγ to the GIRK1 G protein-gated inwardly rectifying K+ channel is important for channel activation , 1995, Neuron.
[281] W. Sadee,et al. Phosphorylation and Agonist‐Specific Intracellular Trafficking of an Epitope‐Tagged μ‐Opioid Receptor Expressed in HEK 293 Cells , 1995, Journal of neurochemistry.
[282] M. Satoh,et al. Molecular biology of the opioid receptors: structures, functions and distributions , 1995, Neuroscience Research.
[283] K. Fukuda,et al. Coupling of the Cloned μ‐Opioid Receptor with the ω‐Conotoxin‐Sensitive Ca2+ Current in NG108‐15 Cells , 1995 .
[284] D. Lambert,et al. Mu-opioid activation of phospholipase C in SH-SY5Y cells rapidly desensitizes: mechanistic studies. , 1995, Biochemical Society transactions.
[285] H. Ueda,et al. Opioid μ- and κ-receptor mediate phospholipase C activation through Gi1 in Xenopus oocytes , 1995 .
[286] R. Lefkowitz,et al. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. , 1995, Molecular pharmacology.
[287] J. Kiang,et al. Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells. , 1995, Molecular pharmacology.
[288] M. Simon,et al. Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.
[289] H. Loh,et al. Expression of the μ‐Opioid Receptor in CHO Cells: Ability of μ‐Opioid Ligands to Promote α‐Azidoanilido[32P]GTP Labeling of Multiple G Protein α Subunits , 1995 .
[290] Y. Wong,et al. Regulation of Multiple Effectors by the Cloned δ‐Opioid Receptor: Stimulation of Phospholipase C and Type II Adenylyl Cyclase , 1995, Journal of neurochemistry.
[291] R. Stoffel,et al. A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits. , 1995, Science.
[292] H. Loh,et al. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. , 1995, Molecular pharmacology.
[293] A. Kuznetsov,et al. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes. , 1995, Molecular pharmacology.
[294] H. Loh,et al. Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual Gα subunit and is similar to that of other opioid receptors , 1995 .
[295] T. Katada,et al. A subtype of opioid κ‐receptor is coupled to inhibition of Gil‐mediated phospholipase C activity in the guinea pig cerebellum , 1995, FEBS letters.
[296] D. Grandy,et al. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. , 1995, Molecular pharmacology.
[297] N. Davidson,et al. A G protein-gated K channel is activated via beta 2-adrenergic receptors and G beta gamma subunits in Xenopus oocytes , 1995, The Journal of general physiology.
[298] Y. Wong,et al. GZ coupling to the rat κ‐opioid receptor , 1995 .
[299] D. Lambert,et al. Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. , 1995, The Biochemical journal.
[300] H. Rhim,et al. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[301] H. Loh,et al. Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density. , 1994, The Journal of biological chemistry.
[302] C. Kozak,et al. Murine Chromosomal Location of the μ and κ Opioid Receptor Genes , 1994 .
[303] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[304] R. Macdonald,et al. mu-Opioid receptor-mediated reduction of neuronal calcium current occurs via a G(o)-type GTP-binding protein , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[305] H. Loh,et al. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. , 1994, Molecular pharmacology.
[306] D. Clapham,et al. Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel , 1994, Nature.
[307] D. Lambert,et al. μ‐Opioid Receptor Stimulation of Inositol (1,4,5)Trisphosphate Formation via a Pertussis Toxin‐Sensitive G Protein , 1994, Journal of neurochemistry.
[308] R. Taussig,et al. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. , 1994, The Journal of biological chemistry.
[309] D. Kaufman,et al. Localization of the δ-Opioid Receptor Gene to Mouse Chromosome 4 by Linkage Analysis , 1994 .
[310] J. Williams,et al. kappa-Opioid receptors also increase potassium conductance. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[311] A Goldstein,et al. Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[312] Lei Yu,et al. Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.
[313] B. Carter,et al. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[314] H. Loh,et al. Opioid-induced inhibition of voltage-gated calcium channels parallels expression of ω-conotoxin-sensitive channel subtype during differentiation of NG108-15 cells , 1993, Brain Research.
[315] B. Dvorkin,et al. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[316] G. Dawson,et al. Opioid peptides activate phospholipase D and protein kinase C-epsilon in chicken embryo neuron cultures. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[317] F. Okajima,et al. Enkephalin activates the phospholipase C/Ca2+ system through cross-talk between opioid receptors and P2-purinergic or bradykinin receptors in NG 108-15 cells. A permissive role for pertussis toxin-sensitive G-proteins. , 1993, The Biochemical journal.
[318] R. Edwards,et al. Cloning of a delta opioid receptor by functional expression. , 1992, Science.
[319] K. Befort,et al. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[320] H. Loh,et al. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. , 1992, Molecular pharmacology.
[321] C. Aoki,et al. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. , 1992, The Journal of biological chemistry.
[322] G. Schultz,et al. Different β-subunits determine G-protein interaction with transmembrane receptors , 1992, Nature.
[323] H. Loh,et al. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. , 1992, Molecular pharmacology.
[324] B. Conklin,et al. Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunits , 1992, Nature.
[325] B. Conklin,et al. Gz-mediated hormonal inhibition of cyclic AMP accumulation. , 1992, Science.
[326] G. Schultz,et al. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents , 1991, Nature.
[327] P. Portoghese,et al. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. , 1991, The Journal of pharmacology and experimental therapeutics.
[328] G. Schultz,et al. Evidence for opioid receptor-mediated activation of the G-proteins, Go and Gi2, in membranes of neuroblastoma x glioma (NG108-15) hybrid cells. , 1991, The Journal of biological chemistry.
[329] Frank McCormick,et al. The GTPase superfamily: a conserved switch for diverse cell functions , 1990, Nature.
[330] M. Caron,et al. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.
[331] G. Milligan,et al. Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. , 1990, The Biochemical journal.
[332] J. Axelrod,et al. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[333] A. Herz,et al. Sodium modulates opioid receptors through a membrane component different from G-proteins. Demonstration by target size analysis. , 1988, The Journal of biological chemistry.
[334] P. Portoghese,et al. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. , 1988, The Journal of pharmacology and experimental therapeutics.
[335] B. Dvorkin,et al. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin , 1988, Brain Research.
[336] P. Portoghese,et al. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist , 1988 .
[337] J T Williams,et al. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[338] G. Schultz,et al. The GTP-binding protein, Go9 regulates neuronal calcium channels , 1987, Nature.
[339] F. Tirone,et al. Pertussis toxin inhibits the antinociceptive action of morphine in the rat. , 1986, European journal of pharmacology.
[340] H. Loh,et al. Involvement of Both Inhibitory and Stimulatory Guanine Nucleotide Binding Proteins in the Expression of Chronic Opiate Regulation of Adenylate Cyclase Activity in NG108‐15 Cells , 1985, Journal of neurochemistry.
[341] M. Luján,et al. Pertussis toxin blocks the action of morphine, norepinephrine and clonidine on isolated guinea-pig ileum. , 1984, European journal of pharmacology.
[342] E. Hewlett,et al. ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. , 1984, The Journal of biological chemistry.
[343] T. Katada,et al. Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. , 1983, The Journal of biological chemistry.
[344] R. Barrett,et al. The effects of receptor selective opioid peptides on morphine-induced analgesia. , 1982, European journal of pharmacology.
[345] P. Portoghese,et al. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. , 1982, The Journal of pharmacology and experimental therapeutics.
[346] P. Cuatrecasas,et al. Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. , 1981, Molecular pharmacology.
[347] J. Wu,et al. Demonstration and Characterization of Opiate Inhibition of the Striatal Adenylate Cyclase , 1981, Journal of neurochemistry.
[348] D. L. Larson,et al. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. , 1981, European journal of pharmacology.
[349] A. Goldstein,et al. Immunoreactive dynorphin in pituitary and brain. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[350] C. Chavkin,et al. A specific radioimmunoassay for the novel opioid peptide dynorphin. , 1980, Life sciences.
[351] R. Schulz,et al. Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens , 1980, Nature.
[352] A. Blume,et al. Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[353] P. Cuatrecasas,et al. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. , 1979, Molecular pharmacology.
[354] N. Flesness,et al. Kinship asymmetry in diploids , 1978, Nature.
[355] Choh Hao Li,et al. ISOLATION, STRUCTURE, SYNTHESIS AND MORPHINE‐LIKE ACTIVITY OF β‐ENDORPHIN FROM HUMAN PITUITARY GLANDS * , 1977, Annals of the New York Academy of Sciences.
[356] M. Nirenberg,et al. Opiate-dependent modulation of adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[357] John Hughes,et al. Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.
[358] H. Loh,et al. beta-endorphin is a potent analgesic agent. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[359] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[360] H. Morris,et al. Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.
[361] H. Collier,et al. Morphine abstinence is associated with increased brain cyclic AMP , 1975, Nature.
[362] L. Volicer,et al. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum. , 1975, Life sciences.
[363] M. Nirenberg,et al. Morphine receptors as regulators of adenylate cyclase activity. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[364] H. Collier,et al. Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate , 1974, Nature.
[365] S. Snyder,et al. Properties of opiate-receptor binding in rat brain. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[366] E. J. Simon,et al. Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[367] A. Goldstein,et al. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[368] Z. Vogel,et al. Adenylyl cyclase type-VIII activity is regulated by Gβγ subunits , 2006 .
[369] A. López-Fando,et al. Expression of Neural RGS-R7 and Gβ5 Proteins in Response to Acute and Chronic Morphine , 2005, Neuropsychopharmacology.
[370] L. Devi,et al. Opioid Receptor Oligomerization , 2003 .
[371] D. Witherow,et al. A Novel Kind of G Protein Heterodimer: The Gβ5-RGS Complex , 2003 .
[372] S. Rhee,et al. Regulation of phosphoinositide-specific phospholipase C. , 2001, Annual review of biochemistry.
[373] G. Dawson,et al. Multiple polyphosphoinositide pathways regulate apoptotic signalling in a dorsal root ganglion derived cell line , 2000, Journal of neuroscience research.
[374] H. Loh,et al. Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.
[375] E M Ross,et al. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.
[376] E. J. Simon,et al. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. , 1999, Journal of neurochemistry.
[377] D. Mangoura,et al. Diversity of the endogenous opioid system in development. Novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. , 1998, Perspectives on developmental neurobiology.
[378] H. Loh,et al. Agonist Activation of δ-Opioid Receptor but not μ-Opioid Receptor Potentiates Fetal Calf Serum or Tyrosine Kinase Receptor-Mediated Cell Proliferation in a CellLine-Specific Manner , 1997 .
[379] B. Conklin,et al. Gz-mediated inhibition of cAMP accumulation , 1992 .
[380] K. Aktories,et al. Pertussis toxin decreases opiate receptor binding and adenylate inhibition in a neuroblastoma x glioma hybrid cell line. , 1983, Life sciences.
[381] A. Takemori,et al. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. , 1979, The Journal of pharmacology and experimental therapeutics.
[382] H. Loh,et al. 3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone. , 1978, Research communications in chemical pathology and pharmacology.